COMMUNIQUÉS West-GlobeNewswire

Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights
14/08/2018
Company reports second quarter net product sales of $1.3 million and that more than 2,600 physicians have prescribed XHANCE since launch Conference call and webcast to be held today at 8:00 a.m. Eastern Time YARDLEY, Pa [...]
Establishment Labs Reports Second Quarter 2018 Financial Results
14/08/2018
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]
Microbix Reports Record Third Quarter Sales
14/08/2018
Year-Over-Year Sales Growth of 24% in First Nine Months TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports financial [...]
UroGen Pharma Reports Second Quarter 2018 Financial Results and Recent Corporate Developments
14/08/2018
Plan to Initiate Q4 2018 Rolling New Drug Application (NDA) Submission to the U.S. Food and Drug Administration (FDA) for UGN-101, Ahead of Initial Projection of Q1 2019 Initiated Phase 2b Clinical Trial of UGN-102 ( [...]
Auxly Announces Product Strategy Update and World-Class Additions to Dosecann's Management Team
14/08/2018
VANCOUVER, British Columbia, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to provide an update on the product strategy of the Company’s wholly owned [...]
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2018
14/08/2018
Second Product Program, NZV930 Enters Clinical Development CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation [...]
Neuronetics Reports Second Quarter 2018 Financial and Operating Results
14/08/2018
MALVERN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
Athenex, Inc. Announces Second Quarter 2018 Results and Provides Corporate Update
14/08/2018
Second quarter revenue increased to $11.6 million compared to $4.6 million in the same period last year. Received a strategic investment of $100 million from Perceptive Advisors Primary endpoints achieved in two Phase 3 [...]
ReWalk Robotics Reports Second Quarter 2018 Financial Results
14/08/2018
— Total revenue of $1.8 million during the second quarter of 2018 — — VA updates national coverage policy which expands access to ReWalk exoskeletons — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Aug. 14, 2018 (GLOBE [...]
Sharps Compliance Reports Fiscal 2018 Fourth Quarter and Year End Results
14/08/2018
Fourth quarter 2018 revenue was $9.9 million with gross margin of 30% and net loss per share of $0.01 Unused Medication solutions business increased 62% Route-based business increased 21% Unused medication management [...]
Eyenovia Reports Second Quarter 2018 Financial Results
14/08/2018
NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]
HEXO Applauds the Ontario Governments Proposed Retail Framework
14/08/2018
GATINEAU, Quebec, Aug. 14, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) supports the Ontario government’s announcement that they are planning a consultation for private [...]
HEXO applaudit le cadre de vente au détail proposé par le gouvernement de l’Ontario
14/08/2018
GATINEAU, Québec, 14 août 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX: HEXO) accueille avec joie l’annonce du gouvernement de l’Ontario concernant son projet de consultation sur [...]
Aptinyx Reports Second Quarter 2018 Financial and Business Results
14/08/2018
Completed upsized initial public offering that raised $117.8 million in gross proceeds EVANSTON, Ill., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing [...]
SteadyMed Provides Corporate Update and Reports Second Quarter 2018 Financial Results
14/08/2018
SAN RAMON, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]
TLC Doses First Patients in Phase I/II Trial of TLC590 for Postsurgical Pain Management
14/08/2018
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO; “TLC”), a clinical-stage specialty pharmaceutical company dedicated to the development and [...]
C-RAD has appointed Cecilia Danckwardt-Lillieström as new CFO
14/08/2018
C-RAD today announces that Cecilia Danckwardt-Lillieström has been appointed Chief Financial Officer effective October 15, 2018, succeeding Therése Björklund who will assume another position within the finance [...]
Reminder Invitation C-RAD Web Presentation Half-Year Report 2018
14/08/2018
Presentation of the report for the first half of the fiscal year 2018: Date: Friday August 17, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-Year Report 2018 Procedure: Please register online through the [...]
Navamedic signs Sippi® agreement with Sweden's second largest county
14/08/2018
Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, announced today that it has entered a contract with Västra Götalands Regionen (VGR) on its proprietary digital urinmeter Sippi®. VGR [...]

Pages